Ginkgo biloba can increase bleeding risk when taken with anticoagulants.
Ginkgo biloba may potentiate the effects of anticoagulants, increasing bleeding risks.
Patients on anticoagulants should avoid Ginkgo biloba unless supervised by a physician.
The combination may escalate the potential for serious complications.
Monitoring for signs of excessive bleeding is essential.
Ginkgo biloba contains compounds that can inhibit platelet aggregation, which can compound the effects of anticoagulants, leading to an increased risk of bleeding. This effect occurs because Ginkgo affects the coagulation cascade and may alter blood viscosity, thus interfering with normal hemostasis. When taken together, the pharmacodynamic interaction enhances the anticoagulant effect, increasing the likelihood of hemorrhagic events in susceptible populations.
Increased risk of bleeding, including spontaneous bruising, gastrointestinal bleeding, or intracranial hemorrhage.
Patients should be advised to discontinue Ginkgo biloba prior to surgery or if they experience unusual bleeding. Regular monitoring of INR levels may be required in patients using anticoagulants.
Was this helpful?
The content on SafeTo is for informational purposes only and does not constitute medical, veterinary, or professional advice. Always consult with a qualified professional for specific concerns.
